• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Thrombosis/Thrombus (4440); Restenosis (4576)
Event Date 02/20/2023
Event Type  Injury  
Event Description
It was reported that in-stent restenosis and thrombosis occurred.On (b)(6) 2022, selective right lower extremity arteriogram, atherectomy, and balloon angioplasty of the right superficial femoral, popliteal, tibioperoneal trunk, and anterior tibial arteries were performed, which included stenting of the right superficial femoral artery (sfa).The patient had right left leg ischemia.During the procedure, a 6x120mm eluvia drug-eluting stent was deployed in standard fashion in the distal sfa.It was post-dilated with a 5x150mm balloon.Final imaging showed an excellent result with no residual stenosis and brisk flow to the foot.The patient tolerated the procedure well and was taken to the recovery area in good condition.On (b)(6) 2023, aortogram, selective right lower extremity arteriogram, balloon angioplasty of right popliteal artery, and lysis catheter placement were performed to treat peripheral artery disease and acute limb ischemia.During the procedure, it was observed that the sfa was occluded in the mid thigh just above the previously placed eluvia stent.The stent was occluded.A non-boston scientific guidewire and 035 rubicon crossing catheter were advance into the occluded sfa.The wire and catheter advanced relatively easily through the occluded sfa, suggesting the presence of relatively fresh thrombus.There was difficulty advancing the wire and catheter at the level of the above-knee popliteal.Therefore, the physician downsized to a v18 wire and 018 rubicon catheter.The wire and catheter were able to be advanced into the anterior tibial artery.Intraluminal position in the anterior tibial was confirmed by catheter injection.Given the physician's suspicion for significant thrombus, the physician decided to place a lysis catheter.A 4f non-boston scientific infusion catheter with a 50cm infusion length was advanced over the wire.However, at the level of the popliteal artery just above the knee joint, resistance was felt, and the catheter was unable to be advanced further.A tight atherosclerotic lesion was suspected at this level.Therefore, balloon angioplasty was performed.A 3x100mm balloon was advanced over the wire and inflated at this level for 3 minutes.The non-boston scientific infusion catheter was then able to be advanced into the proximal anterior tibial.The catheter was packed with 2mg of tpa.The patient tolerated the procedure well and was taken to the recovery area to await ambulance transport to the hospital for inpatient catheter directed thrombolysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jeff wallner
4100 hamline ave n
arden hills, MN 55112
6515811560
MDR Report Key16649195
MDR Text Key312398889
Report Number2124215-2023-14963
Device Sequence Number1
Product Code NIU
UDI-Device Identifier08714729876618
UDI-Public08714729876618
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/30/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/22/2023
Device Model Number24657
Device Catalogue Number24657
Device Lot Number0028397662
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/22/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
Patient SexFemale
-
-